These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9133513)

  • 21. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
    J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
    Dargie HJ; Ford I; Fox KM
    Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST).
    Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Handberg E; Hill JA; Miller E; Marks RG; Thadani U
    Circulation; 1994 Aug; 90(2):762-8. PubMed ID: 8044945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Symptomatic and silent myocardial ischemia during drug therapy and after aortocoronary bypass].
    Meluzín J; Zeman K; Cerný J; Simek P; Julínek J
    Vnitr Lek; 1995 Nov; 41(11):739-43. PubMed ID: 8553591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
    Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group.
    Pepine CJ; Bourassa MG; Chaitman BR; Davies RF; Kerensky RA; Sharaf B; Knatterud GL; Forman SA; Pratt CM; Staples ED; Sopko G; Conti CR
    J Card Surg; 1999; 14(1):1-8. PubMed ID: 10678439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
    Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
    Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
    Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
    J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
    Kones R
    Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymptomatic cardiac ischemia pilot (ACIP).
    Conti CR; Bourassa MG; Chaitman BR; Geller NL; Knatterud GL; Pepine CJ; Pratt C; Sopko G
    Trans Am Clin Climatol Assoc; 1995; 106():77-83; discussion 83-4. PubMed ID: 7483181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris].
    Idrisova EM; Borovkova NV; Stepacheva TA; Chernov VI; Karpov RS
    Klin Med (Mosk); 2001; 79(1):37-40. PubMed ID: 11234265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
    Dodi C; Pingitore A; Sicari R; Bruno G; Cordovil A; Picano E
    Eur Heart J; 1997 Feb; 18(2):242-7. PubMed ID: 9043840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
    Akhras F; Jackson G
    Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Karpov IuA
    Kardiologiia; 2005; 45(12):87-92. PubMed ID: 16353053
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of asymptomatic myocardial ischemia.
    Mooss AN; Hilleman DE; Mohiuddin SM
    South Med J; 1999 Oct; 92(10):967-70. PubMed ID: 10548168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.